Search for: "In Re: Fosamax Products Liability Litigation"
Results 1 - 20
of 98
Sort by Relevance
|
Sort by Date
12 Mar 2024, 12:46 pm
Moye from giving such testimony); In re Rezulin Products Liab. [read post]
30 Mar 2022, 7:01 pm
Worth our note is a recent preemption decision in In re Fosamax (Alendronate Sodium) Products Liability Litigation, 2022 WL 855853 (D.N.J. [read post]
24 Mar 2022, 11:25 am
For some analysis of this March 23, 2022 Opinion for the federal court Fosamax MDL lawsuits -- captioned In Re Fosamax (Alendronate Sodium) Products Liability Litigation -- we turn to this New Jersey Law Journal article, "Ending a 14-Year Battle, Merck Wins Dismissal of Suits Linking Fosamax to Fractured Femurs", by veteran legal reporter Charles Toutant: The ruling brings an end to roughly 500 suits in litigation… [read post]
2 May 2019, 10:44 am
Rev. 235 (2000). [3] In re Silica Products Liab. [read post]
12 Dec 2018, 12:38 pm
No discovery means no liability. [read post]
24 Mar 2017, 6:07 am
In more detail, the so-called federal court Fosamax MDL is properly titled: In re: Fosamax (Alendronate Sodium) Products Liability Litigation. [read post]
24 Aug 2015, 5:00 am
McNeil Consumer Healthcare, 615 F.3d 861 (7th Cir. 2010); In re Fosamax, 951 F. [read post]
13 Aug 2015, 10:56 am
Once approved, “major changes” to the labeling of a pharmaceutical product again require FDA preapproval. [read post]
26 May 2015, 7:42 am
We thought we’d take a look at what law exists concerning the intersection of pharmacogenomics, personalized medicine, and prescription medical product liability litigation. [read post]
31 Dec 2014, 5:00 am
We’re celebrating the new year in our usual style, with our annual top ten best prescription medical product liability litigation decisions of 2014. [read post]
7 Nov 2014, 5:52 am
SeeRestatement (Third) of Torts, Products Liability §2, reporters notes to comment l (1998). [read post]
22 Aug 2014, 9:22 am
In In re Avandia Marketing, Sales Practices & Products Liability Litigation, 817 F. [read post]
1 May 2014, 4:59 am
So we read the decision in In re: Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (Gannon), No. 3:13-cv-10143-DRH-PMF, 2014 U.S. [read post]
30 Apr 2014, 10:11 am
Thanks to Terry Henryat Blank Rome for sending along today’s preemption decision in In re Fosamax (Alendronate Sodium) Products Liability Litigation (No. [read post]
29 Apr 2014, 1:13 pm
More Blog Posts: Fosamax Plaintiff Receives $285,000 Verdict After Jury Trial, Pharmacy Error Injury Lawyer Blog, February 12, 2013 Pharmaceutical Company Allegedly Knew of Harmful Fosamax Side Effects as Far Back as 2004, According to Review of Internal Documents: In Re: Fosamax Products Liability Litigation, Pharmacy Error Injury Lawyer Blog, December 5, 2012 Fosamax Lawsuit in New York May Proceed, but With Limitations,… [read post]
22 Apr 2014, 10:45 am
The Judicial Panel on Multidistrict Litigation (JPML) has consolidated lawsuits filed around the country against the pharmaceutical company Pfizer under the style In Re Lipitor (Atorvastatin Calcium) Marketing, Sales Practices and Products Liability Litigation (No. [read post]
26 Mar 2014, 1:11 pm
However, that case, In re Fosamax Products Liability Litigation, 951 F. [read post]
6 Mar 2014, 12:41 pm
Accord In re Fosamax Alendronate Sodium Products Liability Litigation, 2013 WL 1558697, at *7-8 (D.N.J. [read post]
21 Feb 2014, 8:53 am
” In re Fosamax Products Liability Litigation, 2013 WL 174416, at *1 (S.D.N.Y. [read post]
31 Jan 2014, 2:00 pm
Wyeth Pharmaceuticals, Inc., 737 F.3d 378, 397 (6th Cir. 2013) (Tennessee would not apply consumer expectation test to drugs).In our prior “bullseye” post we praised In re Fosamax Products Liability Litigation, ___ F. [read post]
